BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24378736)

  • 1. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors.
    Imbernon M; Whyte L; Diaz-Arteaga A; Russell WR; Moreno NR; Vazquez MJ; Gonzalez CR; Díaz-Ruiz A; Lopez M; Malagón MM; Ross RA; Dieguez C; Nogueiras R
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):159-69. PubMed ID: 24378736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.
    Moreno-Navarrete JM; Catalán V; Whyte L; Díaz-Arteaga A; Vázquez-Martínez R; Rotellar F; Guzmán R; Gómez-Ambrosi J; Pulido MR; Russell WR; Imbernón M; Ross RA; Malagón MM; Dieguez C; Fernández-Real JM; Frühbeck G; Nogueiras R
    Diabetes; 2012 Feb; 61(2):281-91. PubMed ID: 22179809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipin1 by nutritional status, adiponectin, sex and pituitary function in rat white adipose tissue.
    González CR; Novelle MG; Caminos JE; Vázquez MJ; Luque RM; López M; Nogueiras R; Diéguez C
    Physiol Behav; 2012 Feb; 105(3):777-83. PubMed ID: 22051776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
    Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
    Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.
    Jenkin KA; McAinch AJ; Zhang Y; Kelly DJ; Hryciw DH
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):256-62. PubMed ID: 25545857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Zac1 gene expression in rat white adipose tissue by androgens.
    Mirowska A; Sledzinski T; Smolenski RT; Swierczynski J
    J Steroid Biochem Mol Biol; 2014 Mar; 140():63-70. PubMed ID: 24316431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
    Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
    J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis.
    Fondevila MF; Fernandez U; Gonzalez-Rellan MJ; Da Silva Lima N; Buque X; Gonzalez-Rodriguez A; Alonso C; Iruarrizaga-Lejarreta M; Delgado TC; Varela-Rey M; Senra A; Garcia-Outeiral V; Novoa E; Iglesias C; Porteiro B; Beiroa D; Folgueira C; Tojo M; Torres JL; Hernández-Cosido L; Blanco Ó; Arab JP; Barrera F; Guallar D; Fidalgo M; López M; Dieguez C; Marcos M; Martinez-Chantar ML; Arrese M; Garcia-Monzon C; Mato JM; Aspichueta P; Nogueiras R
    Hepatology; 2021 Feb; 73(2):606-624. PubMed ID: 32329085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
    Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
    Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55: a new promising target for metabolism?
    Tudurí E; Imbernon M; Hernández-Bautista RJ; Tojo M; Fernø J; Diéguez C; Nogueiras R
    J Mol Endocrinol; 2017 Apr; 58(3):R191-R202. PubMed ID: 28196832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
    Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T
    J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
    AlSuleimani YM; Hiley CR
    Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
    Obara Y; Ueno S; Yanagihata Y; Nakahata N
    PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the natural ligand of GPR55?
    Okuno T; Yokomizo T
    J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.